ILKAY vs. TMO

Last updated Jun 4, 2026

ILKAY (Iluka Resources Ltd ADR) and TMO (Thermo Fisher Scientific Inc.) are both stocks. ILKAY operates in Other Industrial Metals & Mining (Basic Materials), while TMO operates in Diagnostics & Research (Healthcare). Over the past 10 years, ILKAY returned 11.57%/yr vs 12.30%/yr for TMO. At a 0.02 correlation, their price movements are largely independent.

Performance

ILKAY vs. TMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iluka Resources Ltd ADR (ILKAY) and Thermo Fisher Scientific Inc. (TMO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ILKAY achieves a 52.99% return, which is significantly higher than TMO's -18.13% return. Over the past 10 years, ILKAY has underperformed TMO with an annualized return of 11.57%, while TMO has yielded a comparatively higher 12.30% annualized return.

ILKAY

• 1D: -3.21%
• 1M: -0.85%
• YTD: 52.99%
• 6M: 28.50%
• 1Y: 142.51%
• 3Y*: -7.82%
• 5Y*: 0.20%
• 10Y*: 11.57%

TMO

• 1D: -1.69%
• 1M: 2.45%
• YTD: -18.13%
• 6M: -18.21%
• 1Y: 18.94%
• 3Y*: -2.75%
• 5Y*: 1.37%
• 10Y*: 12.30%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ILKAY vs. TMO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ILKAY Iluka Resources Ltd ADR	52.99%	19.25%	-26.93%	-30.67%	-8.72%	83.16%	24.66%	6.24%	-17.73%	44.05%
TMO Thermo Fisher Scientific Inc.	-18.13%	11.78%	-1.72%	-3.36%	-17.29%	43.54%	43.72%	45.55%	18.21%	35.03%

Correlation

The correlation between ILKAY and TMO is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.00
Correlation (5Y) Calculated over the trailing 5-year period	0.02
Correlation (10Y) Calculated over the trailing 10-year period	0.00
Correlation (All Time) Calculated using the full available price history since Feb 7, 2011	0.02

Fundamentals

Market Cap ILKAY : $2.43B TMO : $176.78B
EPS ILKAY : -$1.11 TMO : $18.22
PS Ratio ILKAY : 1.29 TMO : 3.95
PB Ratio ILKAY : 1.18 TMO : 3.40
Total Revenue (TTM) ILKAY : $1.89B TMO : $45.20B
Gross Profit (TTM) ILKAY : $789.87M TMO : $17.81B
EBITDA (TTM) ILKAY : $565.16M TMO : $11.16B

Return for Risk

ILKAY vs. TMO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ILKAY

ILKAY Risk / Return Rank: 83
ILKAY Sharpe Ratio Rank: 87
ILKAY Sortino Ratio Rank: 82
ILKAY Omega Ratio Rank: 82
ILKAY Calmar Ratio Rank: 84
ILKAY Martin Ratio Rank: 79

TMO

TMO Risk / Return Rank: 56
TMO Sharpe Ratio Rank: 61
TMO Sortino Ratio Rank: 56
TMO Omega Ratio Rank: 54
TMO Calmar Ratio Rank: 54
TMO Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ILKAY vs. TMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Iluka Resources Ltd ADR (ILKAY) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ILKAY	TMO	Difference
Sharpe ratio Return per unit of total volatility	1.89	0.62	+1.27
Sortino ratio Return per unit of downside risk	2.43	1.11	+1.31
Omega ratio Gain probability vs. loss probability	1.33	1.13	+0.19
Calmar ratio Return relative to maximum drawdown	3.26	0.61	+2.66
Martin ratio Return relative to average drawdown	6.29	1.38	+4.92
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ILKAY vs. TMO - Sharpe Ratio Comparison

The current ILKAY Sharpe Ratio is 1.89, which is higher than the TMO Sharpe Ratio of 0.62. The chart below compares the historical Sharpe Ratios of ILKAY and TMO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ILKAY	TMO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.89	0.62	+1.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.00	0.05	-0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.23	0.47	-0.24
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.40	-0.33

Drawdowns

ILKAY vs. TMO - Drawdown Comparison

The maximum ILKAY drawdown since its inception was -79.51%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for ILKAY and TMO.

Drawdown Indicators

	ILKAY	TMO	Difference
Max Drawdown Largest peak-to-trough decline	-79.51%	-71.16%	-8.35%
Max Drawdown (1Y) Largest decline over 1 year	-43.96%	-31.38%	-12.58%
Max Drawdown (3Y) Largest decline over 3 years	-76.29%	-37.28%	-39.01%
Max Drawdown (5Y) Largest decline over 5 years	-77.94%	-40.95%	-36.99%
Max Drawdown (10Y) Largest decline over 10 years	-77.94%	-40.95%	-36.99%
Current Drawdown Current decline from peak	-30.66%	-28.10%	-2.56%
Average Drawdown Average peak-to-trough decline	-47.27%	-18.01%	-29.26%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.74%	13.80%	+8.94%

Volatility

ILKAY vs. TMO - Volatility Comparison

Iluka Resources Ltd ADR (ILKAY) has a higher volatility of 16.25% compared to Thermo Fisher Scientific Inc. (TMO) at 9.71%. This indicates that ILKAY's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ILKAY	TMO	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.25%	9.71%	+6.54%
Volatility (6M) Calculated over the trailing 6-month period	46.51%	21.44%	+25.07%
Volatility (1Y) Calculated over the trailing 1-year period	76.31%	30.91%	+45.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	54.59%	27.11%	+27.48%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	51.17%	26.31%	+24.86%

Dividends

ILKAY vs. TMO - Dividend Comparison

ILKAY's dividend yield for the trailing twelve months is around 0.60%, more than TMO's 0.37% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ILKAY Iluka Resources Ltd ADR	0.60%	1.03%	1.68%	3.58%	7.39%	1.33%	73.30%	2.45%	4.10%	0.55%	9.11%	2.95%
TMO Thermo Fisher Scientific Inc.	0.37%	0.30%	0.30%	0.26%	0.22%	0.16%	0.19%	0.23%	0.30%	0.32%	0.43%	0.42%

Financials

ILKAY vs. TMO - Profitability Comparison

The chart below illustrates the profitability comparison between Iluka Resources Ltd ADR and Thermo Fisher Scientific Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ILKAY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Iluka Resources Ltd ADR reported a gross profit of -124.38M and revenue of 429.57M. Therefore, the gross margin over that period was -29.0%.

TMO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported a gross profit of 4.48B and revenue of 11.01B. Therefore, the gross margin over that period was 40.7%.

ILKAY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Iluka Resources Ltd ADR reported an operating income of -205.17M and revenue of 429.57M, resulting in an operating margin of -47.8%.

TMO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported an operating income of 1.86B and revenue of 11.01B, resulting in an operating margin of 16.9%.

ILKAY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Iluka Resources Ltd ADR reported a net income of -373.42M and revenue of 429.57M, resulting in a net margin of -86.9%.

TMO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Thermo Fisher Scientific Inc. reported a net income of 1.65B and revenue of 11.01B, resulting in a net margin of 15.0%.

Frequently Asked Questions

Can I hold both ILKAY and TMO in my portfolio?

ILKAY and TMO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ILKAY or TMO?

ILKAY has higher volatility (16.25%) compared to TMO (9.71%). In terms of maximum drawdown, ILKAY dropped -79.51% vs TMO's -71.16%.

Which has better risk-adjusted returns?

ILKAY currently has the higher Sharpe Ratio (1.89 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.